SB

Samsara BioCapital Portfolio holdings

AUM $489M
This Quarter Return
+25.99%
1 Year Return
+135.25%
3 Year Return
+909.96%
5 Year Return
+774.56%
10 Year Return
AUM
$127M
AUM Growth
+$127M
Cap. Flow
+$11M
Cap. Flow %
8.67%
Top 10 Hldgs %
92.09%
Holding
19
New
2
Increased
2
Reduced
4
Closed
1
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ICPT
1
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$23.6M 18.54% 210,937 -23,438 -10% -$2.62M
ALLK
2
DELISTED
Allakos
ALLK
$18.1M 14.22% 446,905 -11,461 -3% -$464K
ODT
3
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$13.2M 10.35% 595,850
PRNB
4
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$13M 10.25% 383,480
STRO icon
5
Sutro Biopharma
STRO
$72.7M
$12.8M 10.08% 1,125,579 +3 +0% +$34
GOSS icon
6
Gossamer Bio
GOSS
$562M
$11.5M 9.08% +532,920 New +$11.5M
SYRS
7
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$9.69M 7.61% 1,059,938
LQDA icon
8
Liquidia Corp
LQDA
$2.38B
$7.28M 5.72% 639,290 +260,870 +69% +$2.97M
VIRX
9
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$4.56M 3.58% +3,750,000 New +$4.56M
KALV icon
10
KalVista Pharmaceuticals
KALV
$678M
$3.39M 2.66% 118,500 -31,500 -21% -$901K
ARAV
11
DELISTED
Aravive, Inc. Common Stock
ARAV
$3.12M 2.45% 442,733
ATXS icon
12
Astria Therapeutics
ATXS
$349M
$2.38M 1.87% 300,000
EVLO
13
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$1.82M 1.43% 227,529
UROV
14
DELISTED
Urovant Sciences Ltd.
UROV
$1.58M 1.24% 157,480
TPST icon
15
Tempest Therapeutics
TPST
$44M
$677K 0.53% 45,101
SURF
16
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$373K 0.29% 78,300
PDSB icon
17
PDS Biotechnology
PDSB
$57.8M
$68K 0.05% 9,166 -174,166 -95% -$1.29M
TRIL
18
DELISTED
Trillium Therapeutics Inc.
TRIL
$47K 0.04% 71,619
VRDN icon
19
Viridian Therapeutics
VRDN
$1.5B
-909,090 Closed -$2.76M